WallStSmart

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)vsRoyal Bank of Canada (RY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

RY leads profitability with a 33.9% profit margin vs 0.0%. RY trades at a lower P/E of 18.4x. RY earns a higher WallStSmart Score of 63/100 (C+).

OACC

Avoid

28

out of 100

Grade: F

Growth: 3.7Profit: 3.5Value: 4.7Quality: 5.3
Piotroski: 3/9

RY

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 8.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -0.50

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

OACC1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

RY4 strengths · Avg: 9.5/10
Market CapQuality
$291.55B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
33.9%10/10

Keeps 34 of every $100 in revenue as profit

Operating MarginProfitability
46.4%10/10

Strong operational efficiency at 46.4%

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Areas to Watch

OACC4 concerns · Avg: 3.5/10
P/E RatioValuation
38.5x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$264.79M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.6%3/10

ROE of 3.6% — below average capital efficiency

RY4 concerns · Avg: 2.3/10
PEG RatioValuation
2.354/10

Expensive relative to growth rate

Free Cash FlowQuality
$-28.67B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
-0.502/10

Distress zone — elevated risk

Debt/EquityHealth
2.881/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : OACC

The strongest argument for OACC centers on Debt/Equity.

Bull Case : RY

The strongest argument for RY centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 33.9% and operating margin at 46.4%.

Bear Case : OACC

The primary concerns for OACC are P/E Ratio, Revenue Growth, Market Cap.

Bear Case : RY

The primary concerns for RY are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 2.88 is elevated, increasing financial risk.

Key Dynamics to Monitor

OACC profiles as a value stock while RY is a mature play — different risk/reward profiles.

RY is growing revenue faster at 8.9% — sustainability is the question.

OACC generates stronger free cash flow (-97,260), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RY scores higher overall (63/100 vs 28/100), backed by strong 33.9% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

FINANCIAL SERVICES · SHELL COMPANIES · USA

Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) focused on identifying and merging with transformative businesses in the life sciences sector, including healthcare technology, therapeutics, and medical devices. Leveraging the expertise of its experienced management team, OACC aims to drive innovation and generate value through strategic acquisitions and partnerships. With a disciplined investment strategy that emphasizes rigorous due diligence, OACC is well-positioned to capitalize on emerging opportunities within the dynamic life sciences market, thereby enhancing shareholder value amidst evolving industry trends.

Visit Website →

Royal Bank of Canada

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

Royal Bank of Canada is a globally diversified financial services company. The company is headquartered in Toronto, Canada.

Want to dig deeper into these stocks?